<SEC-DOCUMENT>0001104659-26-048793-index.html : 20260424 <SEC-HEADER>0001104659-26-048793.hdr.sgml : 20260424 <ACCEPTANCE-DATETIME>20260424201250 ACCESSION NUMBER: 0001104659-26-048793 CONFORMED SUBMISSION TYPE: SCHEDULE 13G PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20260424 DATE AS OF CHANGE: 20260424 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ACHIEVE LIFE SCIENCES, INC. CENTRAL INDEX KEY: 0000949858 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences EIN: 954343413 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-45969 FILM NUMBER: 26896233 BUSINESS ADDRESS: STREET 1: 22722 29TH DR. SE STREET 2: SUITE 100 CITY: SEATTLE STATE: WA ZIP: 98021 BUSINESS PHONE: 425-686-1500 MAIL ADDRESS: STREET 1: 22722 29TH DR. SE STREET 2: SUITE 100 CITY: SEATTLE STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: ONCOGENEX PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20080821 FORMER COMPANY: FORMER CONFORMED NAME: SONUS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19950825 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Paradigm Biocapital Advisors LP CENTRAL INDEX KEY: 0001855655 ORGANIZATION NAME: EIN: 851451055 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G BUSINESS ADDRESS: STREET 1: 767 THIRD AVENUE, 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 646-970-2123 MAIL ADDRESS: STREET 1: 767 THIRD AVENUE, 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 </SEC-HEADER> <DOCUMENT> <TYPE>SCHEDULE 13G <SEQUENCE>1 <FILENAME>primary_doc.xml <TEXT> Document 1 - file: primary_doc.html
Document 1 - RAW XML: primary_doc.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>tm2612362d1_ex99-1.htm <DESCRIPTION>EXHIBIT 99.1 <TEXT> Document 2 - file: tm2612362d1_ex99-1.htm
</DOCUMENT> </SEC-DOCUMENT>